COUGH is the #8 most commonly reported adverse reaction for AZITHROMYCIN DIHYDRATE, manufactured by Aurobindo Pharma Limited. There are 2,863 FDA adverse event reports linking AZITHROMYCIN DIHYDRATE to COUGH. This represents approximately 2.3% of all 126,693 adverse event reports for this drug.
Patients taking AZITHROMYCIN DIHYDRATE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH2,863 of 126,693 reports
COUGH is a less commonly reported adverse event for AZITHROMYCIN DIHYDRATE, but still significant enough to appear in the safety profile.
Other Side Effects of AZITHROMYCIN DIHYDRATE
In addition to cough, the following adverse reactions have been reported for AZITHROMYCIN DIHYDRATE:
COUGH has been reported as an adverse event in 2,863 FDA reports for AZITHROMYCIN DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with AZITHROMYCIN DIHYDRATE?
COUGH accounts for approximately 2.3% of all adverse event reports for AZITHROMYCIN DIHYDRATE, making it a notable side effect.
What should I do if I experience COUGH while taking AZITHROMYCIN DIHYDRATE?
If you experience cough while taking AZITHROMYCIN DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.